The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vir Biotechnology Inc
NASDAQ:VIR
|
US |
|
Progressive Planet Solutions Inc
F:ARB3
|
CA |
|
Next Geosolutions Europe SpA
MIL:NXT
|
IT |
|
Sato Sho-Ji Corp
F:TI2
|
JP |
|
T
|
TXNM Energy Inc
F:98P
|
US |
|
M
|
Morgan Advanced Materials PLC
OTC:MCRUF
|
UK |
|
T
|
Tencent Holdings Ltd
OTC:TCEHY
|
CN |
|
Tamura Corp
F:5IA
|
JP |
|
B
|
Bristol-Myers Squibb Co
XMUN:BRM
|
US |
|
Mirae ING Co Ltd
KRX:007120
|
KR |
|
O
|
Orogen Royalties Inc
F:5EV
|
CA |
|
Genasys Inc
F:G66
|
US |
|
R
|
Rich Goldman Holdings Ltd
F:MRU3
|
HK |
|
V
|
Victoria PLC
OTC:VCCTF
|
UK |
|
C
|
Cellcom Israel Ltd
TASE:CEL
|
IL |
|
I
|
iWin Plus Co Ltd
KOSDAQ:123010
|
KR |
|
E
|
Enel SpA
F:ENL
|
IT |
|
C
|
Cosmo Metals Ltd
ASX:CMO
|
AU |
|
McGrath RentCorp
F:MG8
|
US |
|
Doubleview Gold Corp
F:1D4
|
CA |
|
Quoin Pharmaceuticals Ltd
F:2EB0
|
IL |
|
J
|
Japan Post Holdings Co Ltd
F:1JP
|
JP |
|
O
|
Obayashi Corp
F:OBA
|
JP |
|
D
|
DTE Energy Co
F:DGY
|
US |
Vir Biotechnology Inc (VIR)’s 12-month stock price forecast through October 2027 has a consensus target of $21.42, implying 104% upside. The forecast is based on price targets from 10 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
VIR is 21.42 USD with a low forecast of 15.15 USD and a high forecast of 31.5 USD.
Over the last 7 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 8 years is 46%.
The compound annual growth rate for Gross Profit over the next 8 years is 43%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more